News

Carmot is expected to use the FBLD technology, called ‘Chemotype Evolution,’ for identifying drug candidates in a broad range of therapeutic areas, including inflammatory, metabolic, and neurodegenerative diseases.

The company has provided a literature review supporting it’s belief that administration of exogenous testosterone at doses resulting in morning testosterone levels within the normal range, render a

The study and the ongoing Phase 3 trial in chronic kidney disease patients are directed toward fulfilling licensure requirements in the US, Canada and Europe. Heplisav has been

Tramadol/APAP is a centrally-acting analgesic indicated for the short-term management of moderately severe acute pain. The product is designated as a controlled substance in some states. Amneal began

The company’s Hafnarfjordur facility in Iceland is a manufacturing site which exports 95% of its products. After expansion, the SOD-site‘s capacity will increase to 1.5 billion tablets per

The company said that as a late Phase 2 oncology product, Tesetaxel is the leading oral taxane currently in clinical development. Unlike standard Taxanes (paclitaxel [Taxol] or Docetaxel

The Amlodipine/Benazepril capsules are the AB rated generic equivalent of Novartis’ Lorrel capsules indicated for the treatment of hypertension. Nilesh Gupta, group president and executive director of Lupin,

Reportedly, results from a study suggested that variation in PI3K gene can work as a useful biomarker, as a companion diagnostic with several other cancer treatment. The study

The company said that Dr Streeter will relocate to Gainesville, Florida from San Diego, California where he served most recently as the founder and chief scientific officer of